HAUPPAUGE, N.Y. Generic drug maker Amneal Pharmaceuticals has appointed a former Par Pharmaceutical Cos. executive as chief scientific officer and EVP specialty pharmaceuticals, Amneal said.
Shankar Hariharan previously worked for Woodcliff Lake, N.J.-based Par as chief scientific officer and EVP and helped create Par’s branded drug division. Most recently, he was president, CEO and co-founder of DermAct Pharmaceutical, based in Melville, N.Y., and Action Medicines, based in Spain.
“Dr. Shankar Hariharan’s depth of R&D experience, proven results and strong leadership skills bring tremendous value to Amneal as we extend our global reach in both generic and specialty pharmaceuticals,” Amneal CEO Chintu Patel said. “We enthusiastically welcome him to the Amneal family.”